title: First fixed drug eruption due to teicoplanin with a peri-oral distribution.
authors.forename: T
authors.initials: T
authors.lastname: Duong
authors.forename: D
authors.initials: D
authors.lastname: Hamel
authors.forename: S
authors.initials: S
authors.lastname: Benlahrech
authors.forename: K H
authors.initials: KH
authors.lastname: Le Quan Sang
authors.forename: H
authors.initials: H
authors.lastname: Sauvé-Martin
authors.forename: Y
authors.initials: Y
authors.lastname: De Prost
authors.forename: J C
authors.initials: JC
authors.lastname: Roujeau
authors.forename: S
authors.initials: S
authors.lastname: Hadj-Rabia
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003875:Drug Eruptions / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D009055:Mouth / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus; D017334:Teicoplanin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D017334:Teicoplanin